280 related articles for article (PubMed ID: 20658985)
21. Tau and Alzheimer's disease: Past, present and future.
Iqbal K
Cytoskeleton (Hoboken); 2024 Jan; 81(1):116-121. PubMed ID: 38126608
[TBL] [Abstract][Full Text] [Related]
22. Targeting tau protein in Alzheimer's disease.
Gong CX; Grundke-Iqbal I; Iqbal K
Drugs Aging; 2010 May; 27(5):351-65. PubMed ID: 20450234
[TBL] [Abstract][Full Text] [Related]
23. The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death.
Thal DR; Tomé SO
Brain Res Bull; 2022 Nov; 190():204-217. PubMed ID: 36244581
[TBL] [Abstract][Full Text] [Related]
24. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
25. CIP2A Causes Tau/APP Phosphorylation, Synaptopathy, and Memory Deficits in Alzheimer's Disease.
Shentu YP; Huo Y; Feng XL; Gilbert J; Zhang Q; Liuyang ZY; Wang XL; Wang G; Zhou H; Wang XC; Wang JZ; Lu YM; Westermarck J; Man HY; Liu R
Cell Rep; 2018 Jul; 24(3):713-723. PubMed ID: 30021167
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
[TBL] [Abstract][Full Text] [Related]
27. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
28. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies.
Moore KBE; Hung TJ; Fortin JS
Drug Discov Today; 2023 Mar; 28(3):103487. PubMed ID: 36634842
[TBL] [Abstract][Full Text] [Related]
29. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
Chalermpalanupap T; Weinshenker D; Rorabaugh JM
Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
[TBL] [Abstract][Full Text] [Related]
30. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective.
Iqbal K; Grundke-Iqbal I
J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861
[TBL] [Abstract][Full Text] [Related]
31. Tau Proteins and Tauopathies in Alzheimer's Disease.
Chong FP; Ng KY; Koh RY; Chye SM
Cell Mol Neurobiol; 2018 Jul; 38(5):965-980. PubMed ID: 29299792
[TBL] [Abstract][Full Text] [Related]
32. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
33. Tau aggregation is a therapeutic target for Alzheimer's disease.
Takashima A
Curr Alzheimer Res; 2010 Dec; 7(8):665-9. PubMed ID: 20678070
[TBL] [Abstract][Full Text] [Related]
34. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
Brandt R; Hundelt M; Shahani N
Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
[TBL] [Abstract][Full Text] [Related]
35. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
36. Animal models of the sporadic form of Alzheimer's disease: focus on the disease and not just the lesions.
Iqbal K; Bolognin S; Wang X; Basurto-Islas G; Blanchard J; Tung YC
J Alzheimers Dis; 2013; 37(3):469-74. PubMed ID: 23948903
[TBL] [Abstract][Full Text] [Related]
37. Role of protein phosphatase 2A in Alzheimer's disease.
Rudrabhatla P; Pant HC
Curr Alzheimer Res; 2011 Sep; 8(6):623-32. PubMed ID: 21605044
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
Liu R; Zhou XW; Tanila H; Bjorkdahl C; Wang JZ; Guan ZZ; Cao Y; Gustafsson JA; Winblad B; Pei JJ
J Cell Mol Med; 2008; 12(1):241-57. PubMed ID: 18208556
[TBL] [Abstract][Full Text] [Related]
39. [Significance of tau in the development of Alzheimer's disease].
Takashima A
Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
[TBL] [Abstract][Full Text] [Related]
40. Assembly of filamentous tau aggregates in human neuronal cells.
Ko LW; Rush T; Sahara N; Kersh JS; Easson C; Deture M; Lin WL; Connor YD; Yen SH
J Alzheimers Dis; 2004 Dec; 6(6):605-22; discussion 673-81. PubMed ID: 15665401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]